Approval · Notice of Compliance 33018 · 2024
CAPRELSA: Notice of Compliance 33018
Issued April 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33018
- Date
- April 5, 2024
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- VANDETANIB 100 MG per TAB
- VANDETANIB 300 MG per TAB